|
Name |
Aurasperone A
|
Molecular Formula | C32H26O10 | |
IUPAC Name* |
5-hydroxy-7-(5-hydroxy-6,8-dimethoxy-2-methyl-4-oxobenzo[g]chromen-10-yl)-6,8-dimethoxy-2-methylbenzo[g]chromen-4-one
|
|
SMILES |
CC1=CC(=O)C2=C(O1)C=C3C=C(C(=C(C3=C2O)OC)C4=C5C(=C(C6=C4C=C(C=C6OC)OC)O)C(=O)C=C(O5)C)OC
|
|
InChI |
InChI=1S/C32H26O10/c1-13-7-18(33)26-22(41-13)10-15-9-20(38-4)28(31(40-6)23(15)29(26)35)25-17-11-16(37-3)12-21(39-5)24(17)30(36)27-19(34)8-14(2)42-32(25)27/h7-12,35-36H,1-6H3
|
|
InChIKey |
QAHRSPAZSGMZMT-UHFFFAOYSA-N
|
|
Synonyms |
Aurasperone A; Aurasperone; 15085-74-2; B9PTQ8Z021; 5-hydroxy-7-(5-hydroxy-6,8-dimethoxy-2-methyl-4-oxobenzo[g]chromen-10-yl)-6,8-dimethoxy-2-methylbenzo[g]chromen-4-one; (7,10'-Bi-4H-naphtho(2,3-b)pyran)-4,4'-dione, 5,5'-dihydroxy-6,6',8,8'-tetramethoxy-2,2'-dimethyl-; UNII-B9PTQ8Z021; CHEMBL450763; DTXSID30164629; CHEBI:133760; Q27274553; (7,10'-BI-4H-NAPHTHO(2,3-B)PYRAN)-4,4'-DIONE, 5,5'-DIHYDROXY-6,6',8,8'-TETRAMETHOXY-2,2'-DIMETHYL-, (7S)-; 5,5'-Dihydroxy-6,6',8,8'-tetramethoxy-2,2'-dimethyl-7,10'-bi-4H-naphtho[2,3-b]pyran-4,4'-dione, 9CI; 5-HYDROXY-10-{5-HYDROXY-6,8-DIMETHOXY-2-METHYL-4-OXO-4H-BENZO[G]CHROMEN-7-YL}-6,8-DIMETHOXY-2-METHYL-4H-BENZO[G]CHROMEN-4-ONE; 5-hydroxy-7-(5-hydroxy-6,8-dimethoxy-2-methyl-4-oxo-benzo[g]chromen-10-yl)-6,8-dimethoxy-2-methyl-benzo[g]chromen-4-one
|
|
CAS | 15085-74-2 | |
PubChem CID | 3084216 | |
ChEMBL ID | CHEMBL450763 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 570.5 | ALogp: | 6.3 |
HBD: | 2 | HBA: | 10 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 130.0 | Aromatic Rings: | 6 |
Heavy Atoms: | 42 | QED Weighted: | 0.237 |
Caco-2 Permeability: | -5.054 | MDCK Permeability: | 0.00002470 |
Pgp-inhibitor: | 0.976 | Pgp-substrate: | 0.105 |
Human Intestinal Absorption (HIA): | 0.367 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.242 |
Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 64.19% |
Volume Distribution (VD): | 0.449 | Fu: | 51.25% |
CYP1A2-inhibitor: | 0.172 | CYP1A2-substrate: | 0.99 |
CYP2C19-inhibitor: | 0.44 | CYP2C19-substrate: | 0.616 |
CYP2C9-inhibitor: | 0.758 | CYP2C9-substrate: | 0.934 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.909 |
CYP3A4-inhibitor: | 0.077 | CYP3A4-substrate: | 0.283 |
Clearance (CL): | 2.759 | Half-life (T1/2): | 0.133 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.14 |
Drug-inuced Liver Injury (DILI): | 0.98 | AMES Toxicity: | 0.126 |
Rat Oral Acute Toxicity: | 0.193 | Maximum Recommended Daily Dose: | 0.873 |
Skin Sensitization: | 0.127 | Carcinogencity: | 0.017 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.358 |
Respiratory Toxicity: | 0.096 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002093 | 0.933 | D06GCK | 0.381 | ||||
ENC000922 | 0.877 | D0G4KG | 0.290 | ||||
ENC002002 | 0.871 | D02LZB | 0.282 | ||||
ENC000912 | 0.832 | D09DHY | 0.281 | ||||
ENC003154 | 0.813 | D0NJ3V | 0.272 | ||||
ENC003507 | 0.775 | D0V8HJ | 0.249 | ||||
ENC001411 | 0.735 | D0D4HN | 0.248 | ||||
ENC003149 | 0.733 | D0Y6CE | 0.245 | ||||
ENC000984 | 0.733 | D0Y7TS | 0.240 | ||||
ENC003048 | 0.660 | D0V6OA | 0.240 |